Following up on a 2018 study that identified an epigenetic modifier known as histone deacetylase 11 (HDAC11) as a potential therapeutic target for treating obesity and diabetes, researchers from the University of Colorado School of Medicine have published new research that finds HDAC11 regulates G protein-coupled receptors (GPCRs) called beta-adrenergic receptors (β-ARs).
Greg Glasgow | 
February 11, 2022
Cure Today
March 15, 2023
Teri Griege has always loved sports. She participated in high school sports but once she got married, built her career as a nurse and started her family — a son and a daughter — running took a back seat.
Yahoo News
March 14, 2023
Becker's Hospital Review
March 13, 2023
Last year, contract labor in healthcare costs soared 258 percent during the COVID-19 pandemic. With Ascension's operating margin falling to -2.9 percenting and Providence reporting $1.7B in operating losses last year, systems need to think creatively to improve profits.
The Colorado Sun
March 12, 2023
The end of life can be a time of reconciliation. But often not for LGBTQ people who face rampant discrimination and are often shut out by the way people talk and listen to them. Let me give you an example.
